GlassScriptPhysician profile
Manisha A Purohit
NPI 1972721538
$3,493.61
in general payments reported to CMS, 2019-2025
38 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $1,087 · 2021: $375 · 2022: $768 · 2023: $358 · 2024: $217 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $899.49 | 2019-2021 | |
| Abbvie INC. | $364.11 | 2019-2022 | |
| Gynesonics, INC. | $230.18 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $188.03 | 2020-2023 | |
| Mayne Pharma Commercial LLC | $184.96 | 2023-2024 | |
| Allergan, INC. | $183.09 | 2019-2020 | |
| Hologic Sales and Service, LLC | $144.18 | 2019-2024 | Acessa Provu System, Novasure |
| Tempus Ai, INC | $115.29 | 2025 | Xt Cdx |
| Therapeuticsmd, INC. | $95.36 | 2019-2022 | |
| Momentis Surgical INC. | $92.00 | 2022 | |
| Ethicon US, LLC | $83.93 | 2019-2023 | Megadyne, Vistaseal, Ethicon |
| Coopersurgical, INC. | $79.10 | 2019-2025 | Paragard T 380a |
| Myriad Women'S Health, INC. | $75.60 | 2023 | Myrisk |
| Channel Medsystems, INC. | $73.33 | 2022 | |
| Daiichi Sankyo INC. | $60.02 | 2020-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $54.32 | 2021-2022 | |
| Exeltis, USA INC. | $51.97 | 2021 | |
| Sumitomo Pharma America, INC. | $50.14 | 2023 | Myfembree |
| Agile Therapeutics, INC. | $49.83 | 2021-2024 | Twirla |
| Lupin INC. | $39.52 | 2019-2020 | |
| Myovant Sciences INC. | $36.64 | 2022 | |
| Smith+Nephew, INC. | $33.63 | 2021 | |
| Duchesnay USA Incorporated | $27.95 | 2019 | |
| Mylan Pharmaceuticals INC. | $27.46 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $24.24 | 2019 | |
| Becton, Dickinson and Company | $23.44 | 2022 | |
| Astellas Pharma US INC | $22.42 | 2024 | Veozah |
| Meditrina | $20.90 | 2022 | |
| Shield Therapeutics INC | $20.49 | 2024 | |
| Boston Scientific Corporation | $20.08 | 2019 | |
| Baxter Healthcare | $17.94 | 2024 | Perclot |
| Covidien LP | $17.37 | 2019 | |
| Optumhealth Care Solutions, LLC | $16.31 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Monaghan Medical Corporation | $15.64 | 2023 | Aerochamber |
| Organon LLC | $15.25 | 2022 | |
| Merck Sharp & Dohme LLC | $14.05 | 2019 | |
| Minerva Surgical, INC | $14.03 | 2019 | |
| Pfizer INC. | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manisha Purohit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.